Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network

BACKGROUND: Duchenne muscular dystrophy (DMD) is the most commonly inherited neuromuscular disease. Therapeutic agents for the treatment of rare disease, namely “orphan drugs”, have recently drawn the attention of researchers and pharmaceutical companies. To ensure the successful conduction of clini...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Health Serv Res
Autors principals: Shimizu, Reiko, Ogata, Katsuhisa, Tamaura, Akemi, Kimura, En, Ohata, Maki, Takeshita, Eri, Nakamura, Harumasa, Takeda, Shin’ichi, Komaki, Hirofumi
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Technical Advance
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4939632/
https://ncbi.nlm.nih.gov/pubmed/27401940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-016-1477-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars